Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Reliance Steel & Aluminium
RS
$21.7B
| $4.14M | ﹤0.01% |
16,142
+5,039
| +45% | +$1.19M |
|
|
WRK
927
DELISTED
WestRock Company
WRK
| $4.13M | ﹤0.01% |
135,680
-179,918
| -57% | -$5.94M |
|
928
Edison International
EIX
$26.5B
| $4.12M | ﹤0.01% |
58,343
-48
| -0.1% | -$3.24K |
|
929
Gartner
IT
$11.4B
| $4.12M | ﹤0.01% |
12,646
-3,501
| -22% | -$1.16M |
|
930
Essex Property Trust
ESS
$18.1B
| $4.11M | ﹤0.01% |
19,631
+1,946
| +11% | +$429K |
|
931
West Pharmaceutical
WST
$24.8B
| $4.1M | ﹤0.01% |
11,836
-2,543
| -18% | -$743K |
|
932
American Water Works
AWK
$26.9B
| $4.08M | ﹤0.01% |
27,876
-348
| -1% | -$51.5K |
|
933
T. Rowe Price
TROW
$23.7B
| $4.08M | ﹤0.01% |
36,131
-14,544
| -29% | -$1.66M |
|
|
THRX
934
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $4.07M | ﹤0.01% |
+460,728
| New | +$4.52M |
|
|
DFS
935
DELISTED
Discover Financial Services
DFS
| $4.07M | ﹤0.01% |
41,208
+7,583
| +23% | +$812K |
|
936
Arch Capital
ACGL
$33.5B
| $4.06M | ﹤0.01% |
59,873
-23,647
| -28% | -$1.55M |
|
937
Crocs
CROX
$6.22B
| $4.06M | ﹤0.01% |
32,128
+13,479
| +72% | +$1.63M |
|
938
Reinsurance Group of America
RGA
$16.1B
| $4.04M | ﹤0.01% |
30,396
-147,598
| -83% | -$20.9M |
|
939
FTI Consulting
FCN
$4.16B
| $4.04M | ﹤0.01% |
20,456
+13,846
| +209% | +$2.41M |
|
|
PORT
940
DELISTED
Southport Acquisition Corporation
PORT
| $4.03M | ﹤0.01% |
+380,000
| New | +$3.91M |
|
|
VMGA
941
DELISTED
VMG Consumer Acquisition Corp. Class A Common Stock
VMGA
| $4.01M | ﹤0.01% |
387,500
+349,855
| +929% | +$3.6M |
|
942
Kimco Realty
KIM
$16.2B
| $4.01M | ﹤0.01% |
205,298
-121,564
| -37% | -$2.5M |
|
943
Maravai LifeSciences
MRVI
$869M
| $4M | ﹤0.01% |
285,541
+111,120
| +64% | +$1.6M |
|
944
Tractor Supply
TSCO
$18.9B
| $4M | ﹤0.01% |
85,080
+17,500
| +26% | +$797K |
|
945
Zimmer Biomet
ZBH
$18.4B
| $3.99M | ﹤0.01% |
30,935
+6,602
| +27% | +$829K |
|
946
FirstEnergy
FE
$27.2B
| $3.97M | ﹤0.01% |
99,064
+23,768
| +32% | +$960K |
|
|
WBA
947
DELISTED
Walgreens Boots Alliance
WBA
| $3.97M | ﹤0.01% |
114,685
-83,845
| -42% | -$2.98M |
|
948
Franklin Resources
BEN
$17.1B
| $3.96M | ﹤0.01% |
146,936
+16,032
| +12% | +$468K |
|
949
Rollins
ROL
$17.7B
| $3.95M | ﹤0.01% |
105,354
+10,603
| +11% | +$382K |
|
950
Blue Owl Capital
OWL
$19.1B
| $3.94M | ﹤0.01% |
355,385
+50,065
| +16% | +$600K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.